Metixene
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H23NS |
| Molar mass | 309.469 g/mol |
| | |
|
WikiDoc Resources for Metixene |
|
Articles |
|---|
|
Most recent articles on Metixene |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Metixene at Clinical Trials.gov Clinical Trials on Metixene at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Metixene
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Metixene Risk calculators and risk factors for Metixene
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Metixene |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metixene, also known as methixene, is an anticholinergic used as an antiparkinsonian agent.
Schmutz, J.; 1959, Template:US Patent.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Antiparkinsonian agents
- Drug
- Piperidines

